Neurofeedback for Schizophrenia
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it does require that you haven't changed medications in the last 30 days. This suggests you should stay on your current medication without changes.
What data supports the effectiveness of the treatment Neurofeedback for Schizophrenia?
Research suggests that neurofeedback, a technique that helps people learn to control their brain activity, may lead to changes in brain function and improve symptoms in schizophrenia. A case report showed that Infra-Low Frequency Neurofeedback had dramatic effects on reducing psychotic symptoms and anxiety in a patient with schizophrenia. Additionally, a study found that patients who showed a specific learning pattern during neurofeedback training experienced improvements in auditory verbal hallucinations.12345
Is neurofeedback safe for humans?
How is Neurofeedback treatment different from other treatments for schizophrenia?
Neurofeedback is unique because it is a noninvasive treatment that helps patients learn to regulate their brain activity through real-time feedback, unlike traditional medications or therapies. It shows promise in improving cognitive symptoms and overall brain function, which are often not adequately addressed by standard treatments for schizophrenia.12389
What is the purpose of this trial?
This trial tests a computer-based brain training program called Gamma Neurofeedback (G-NFB) for patients with schizophrenia. It aims to improve their memory and cognitive function by helping their brains synchronize better. If successful, it could offer a new way to treat cognitive deficits in these patients.
Eligibility Criteria
This trial is for individuals diagnosed with schizophrenia or schizoaffective disorder. It's not suitable for pregnant individuals, those who've changed medications in the last month, have a history of traumatic brain injury, active substance use disorders within the past month, or a seizure disorder.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive gamma neurofeedback training to enhance gamma band response
Follow-up
Participants are monitored for changes in gamma band response and working memory post-treatment
Treatment Details
Interventions
- Neurofeedback
Neurofeedback is already approved in United States, European Union, Canada for the following indications:
- Chronic low back pain
- Fibromyalgia
- Neuropathic pain
- Chronic pain
- Fibromyalgia
- Neuropathic pain
- Chronic pain
- Fibromyalgia
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Diego
Lead Sponsor
National Institutes of Health (NIH)
Collaborator